201 related articles for article (PubMed ID: 31057792)
21. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
23. Mortality dynamics of Pseudomonas aeruginosa bloodstream infections and the influence of defective OprD on mortality: prospective observational study.
Yoon EJ; Kim D; Lee H; Lee HS; Shin JH; Park YS; Kim YA; Shin JH; Shin KS; Uh Y; Jeong SH
J Antimicrob Chemother; 2019 Sep; 74(9):2774-2783. PubMed ID: 31236593
[TBL] [Abstract][Full Text] [Related]
24. Incidence, antimicrobial resistance and mortality of
Xiao S; Liang X; Han L; Zhao S
Front Public Health; 2023; 11():1294141. PubMed ID: 38249405
[TBL] [Abstract][Full Text] [Related]
25. Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study.
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Abdel Fattah M; Haquin J; Macgowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz De Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Clin Infect Dis; 2020 May; 70(11):2270-2280. PubMed ID: 31323088
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Microb Drug Resist; 2005; 11(1):68-74. PubMed ID: 15770098
[TBL] [Abstract][Full Text] [Related]
27. A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible
Xiao T; Yu W; Niu T; Huang C; Xiao Y
Infect Drug Resist; 2018; 11():595-606. PubMed ID: 29731648
[TBL] [Abstract][Full Text] [Related]
28. High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.
Chaves L; Tomich LM; Salomão M; Leite GC; Ramos J; Martins RR; Rizek C; Neves P; Batista MV; Amigo U; Guimaraes T; Levin AS; Costa SF
J Med Microbiol; 2017 Dec; 66(12):1722-1729. PubMed ID: 29095142
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
Zilberberg MD; Shorr AF
J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
32. The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.
Wu D; Lu W; Huang Y; Qin G; Liu H; Xiao J; Peng J
BMC Infect Dis; 2023 May; 23(1):340. PubMed ID: 37217844
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Liu J; Wang H; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M
J Infect Dev Ctries; 2019 May; 13(5):357-364. PubMed ID: 32053504
[TBL] [Abstract][Full Text] [Related]
34. Carbapenem-resistant
Huang W; Wei X; Xu G; Zhang X; Wang X
Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
37. [The impact of carbapenem-resistance
Wei J; Zhu QL; Sun Z; Wang C
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463
[No Abstract] [Full Text] [Related]
38. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Huang YC; Wu PF; Lin YT; Wang FD
J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
[TBL] [Abstract][Full Text] [Related]
39. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
Yang K; Xiao T; Shi Q; Zhu Y; Ye J; Zhou Y; Xiao Y
J Glob Antimicrob Resist; 2021 Sep; 26():101-107. PubMed ID: 34023532
[TBL] [Abstract][Full Text] [Related]
40. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
